Satisfacción con la atención hospitalaria al final de la vida
María José Zamora Muñoz(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Jesús Rodríguez Marín(Hospital General Universitario de Alicante Doctor Balmis), Irene Portilla, Carlos J. van-der Hofstadt Román(Universitat de Miguel Hernández d'Elx), Sonia Tirado González(Universitat de Miguel Hernández d'Elx), Manuel Valladares(American Society of Clinical Oncology)
Cited by 1
Related Papers
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
|The Oncologist|2012|213
Irinotecan in Combination With Fluorouracil in a 48-Hour Continuous Infusion As First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Spanish Cooperative Group for the Treatment of Digestive Tumors Study
|Journal of Clinical Oncology|2005|98
Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition
|Cellular and Molecular Life Sciences|2013|54
Clinical implications of epithelial cell plasticity in cancer progression
|Cancer Letters|2015|49